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Abstract
Background: The majority of the Ethiopian population is at risk of malaria largely caused by Plasmodium
falciparum. The resistance of the parasite to existing drugs is the main challenge in the control of the disease
and thus new therapeutic drugs are required. In Ethiopia, people use different plant species to treat malaria.
However, very few of them have so far been evaluated for their safety level and antimalarial activity. Thus,
the aim of this study was to evaluate the safety and antimalarial activity of extracts of Ajuga integrifolia,
Clerodendrum myricoides, Melia azedarach, Peponium vogelii and Premna schimperi, locally used by the Sidama
people of Ethiopia to treat malaria.
Methods: The safety level of 80 % methanol extracts of the plants were evaluated using standard acute toxicity test
procedure. The antiplasmodial activity of 80 % methanol extracts of the plants were assessed in vivo using Swiss albino
mice against chloroquine sensitive rodent malaria parasite, Plasmodium berghei, using the standard 4-day suppressive
test procedure at doses of 200,400 and 800 mg/kg/day. The 80 % methanol extract of Ajuga integrifolia that exhibited
better antimalarial activity was fractionated using different solvents and screened for its phytochemical constituents
and evaluated in vivo for its antimalarial activity at doses of 100, 200 and 400 mg/kg/day.
Results: All extracts given at the three different doses caused no lethal effect on mice in 24 h and within 10 days of
observation. All extracts and fractions exhibited antimalarial activity in a dose dependant manner. The highest
inhibition was exhibited by the crude extracts of A. integrifolia (35.17 %) at 800 mg/kg/day (P < 0.05). Among fractions
of A. integrifolia, n-butanol fraction demonstrated the highest inhibition (29.80 %) at 400 mg/kg/day (P < 0.05). The
extracts and fractions prolonged the survival time and prevented weight loss of the mice, but did not prevent PCV
reduction. Phytochemical test on Ajuga integrifolia indicated the presence of alkaloids, flavonoids, saponins, terpenoids,
anthraquinone, steroids, tannins, phenols and fatty acids.
Conclusions: Findings show that the plants are non-toxic and demonstrate antimalarial activity in a dose dependant
manner suporting claims of their traditional therapeutic value for malaria treatment. However, further in-depth
investigation is required to assess the potential of the plants towards the development of new antimalarial agent.
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Background
Malaria continues to be a leading cause of morbidity and
mortality in sub-Saharan African countries, especially
among children under the age of five and pregnant
women [1]. Besides its major public health problem, the
disease also has negative impact on socioeconomic de-
velopment. Malaria mostly affects people in productive
age groups and causes substantial economic loss because
of the compromised capacity and efficiency of the labour
force [2].
Malaria is a major public health problem in Ethiopia;
more than 60 % of the Ethiopian population is at risk of
malaria and approximately 62 % of malaria cases are due
to P. falciparum [3]. Malaria was the leading cause of
morbidity and mortality in the years 2002, 2003 and
2004 [4]. However, since 2005 the incidence of malaria
and death in the country has declined due to scale up of
intervention strategies together with the administration
of artemisin combination therapy (ACT) [5]. However,
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the parasite is less sensitive to antimalarial drugs such as
chloroquine, amodiaquine and sulphadoxine pyrimeth-
amine [6]. There are also reports on parasite resistance
to currently existing first line drug regimen ACT in
parts of Cambodia and Thailand [7] as well as reduced
sensitivity in parts of Africa [8]. Such reports necessitate
a search for new and effective antimalarial drug.
Traditional medicinal remedies are viable treatment al-
ternatives for communities that lack access to available
drugs and they provide an opportunity to introduce
novel antimalarials too. Medicinal plants served as
source of two major antimalarial drugs, quinine from
Peruvian medicinal plant Cinchona succirubra tree bark
and artemisinin from Chinese medicinal plant Artemisia
annua [9].
In Ethiopia, there is a widespread use of traditional
medicine among urban and rural population, which
might be related to accessibility, cultural acceptability
and economic affordability of the system as compared to
modern medicine [10]. Investigations carried out in the
country indicated that traditional healers and indigenous
people in different parts of the country utilize different
species of medicinal plants [11–15] for treatment of
malaria. There are still more other medicinal plants that
are claimed to be effective by local communities in
Ethiopia but not documented and evaluated for their
safety level and antimalarial activity. Thus, the purpose
of this study was to evaluate the antiplasmodial proper-
ties of Ajuga integrifolia, Clerodendrum myricoides,
Melia azedarach, Peponium vogelii and Premna schim-
peri used by the Sidama people, southern Ethiopia and
fraction of Ajuga integrifolia. The five plants were the
ones that had the highest relative frequency of citation
(RFC) as revealed from an ethnobotanical study con-
ducted in Boricha District, Sidama Zone of the South
Region of Ethiopia by the same investigators involved in
the current study. According to Trotter and Logan [16],
plants that are used in some repetitive fashion are more
likely to be biologically active. Previous studies con-
ducted on the plants indicated their antiplasmodial ac-
tivity [17–19]. An in vivo study conducted on water
extract of Ajuga remota, a close relative of A. integrifolia
treated mice showed 90.4 % parasitaemia suppression at
a dose of 30 μg/mL [17]. Aqueous, methanol and dichlo-
romethane extracts of the root bark of C. myricoides ex-
hibited in vitro antimalarial activity with IC50 values of
64 μg/mL, 48.2 μg/mL, 15. μg/mL, respectively [18]. A
study conducted on bark extract of M. azedarach re-
vealed an in vitro antimalarial activity with IC50 value of
66.2 μg/mL [19]. Study carried out on crude methanol
extract and fractions of petroleum ether, dichlorometh-
ane and ethyl acetate of the bark of Premna angolensis,
relative species of P. schimperi, indicated antimalarial ac-
tivity with IC50 values of 180, 250, 250 and 250 μg/mL,
respectively [20]. Phytochemical screening conducted on
C. myricoides showed the presence of secondary metabo-
lites such as saponins, phytosteroides, polyphenols, fla-
vonoides, tannins and alkaloids [21].
Methods
Plant collection
For the in vivo test, samples of Ajuga integrifolia, Clero-
dendrum myricoides, Melia azedarach, Peponium vogelii
and Premna schimperi were collected from Boricha Dis-
trict, southern Ethiopia, during one of the field trips to
the area. Specimen of each plant was dried, identified at
Aklilu Lemma Institute of Pathobiology and National
Herbarium of Addis Ababa University and voucher de-
posited at the National Herbarium.
Preparation of crude extracts
Parts of the plant samples were shade dried, ground
using electric grinding mill (Laboratory mill, Arthuur A.
Thomas company Philadelphia, USA), sieved by using
sieve number 85, weighed using electronic balance and
placed in plastic bags until extraction. One hundred
gram of each powdered medicinal plant part was ex-
tracted with 500 mL of 80 % methanol using a soxhlet
extractor [22]. Then, methanol was removed using ro-
tary evaporator at a temperature of about 40–45 °C and
the water part was removed using freeze dryer (lyophi-
lizer). The dried extract of each plant part was collected
in labeled airtight small bottles and kept in deep freezer
until used.
Fractionation of crude extracts
Ajuga integrifolia, a plant with better antimalarial effect,
was further fractionated using solvent fractionation tech-
nique [23]. Sequential solvent partitioning of the 80 %
methanol crude extract was conducted to get different
solvent fractions. Twenty grams of the extract was sus-
pended in 350 mL of distilled water in a separatory fun-
nel. The aqueous portion was partitioned three to four
times with 100 mL of chloroform to obtain chloroform
fraction. Then, aqueous residue was further fractionated
three to four times with 100 mL of n-butanol to obtain
n-butanol fraction. Finally, the aqueous solution was col-
lected as the third fraction. The chloroform and n-
butanol fractions were concentrated in a rotary evapor-
ator. The aqueous fraction was frozen in refrigerator
overnight and then, dried using a lyophilizer. The frac-
tions obtained were put in airtight bottles and stored in
a refrigerator at 4 °C until used.
Phytochemical screening
Phytochemical screening to test for the presence of sec-
ondary metabolites (alkaloids, terpenoids, flavonoids,
tannins, saponins, steroids, anthraquinon and phenols)
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and proteins, carbohydrates, and fats and oils in the
crude extract of A. integrifolia was carried out using
standard procedures [24].
In vivo acute toxicity test
Acute toxicity test of the extracts was conducted in
Swiss albino male mice of six to eight weeks of age and
weighing 25–30 g. The test was performed by randomly
dividing 30 mice into six groups of five mice per cage.
The mice were fasted over night and groups 1 to 5 re-
ceived 2000 mg/kg of the extract, whereas control
(group 6) mice received the vehicle, distilled water [25].
Then, the mice were observed for any gross behavioral
change and death one hour after the treatment, intermit-
tently for four hours, and thereafter over a period of
24 h. The mice were further observed for 10 days.
In vivo antimalarial test
The test was carried out based on the four-day suppres-
sive test described by Peters et al. [26]. Male Swiss al-
bino mice weighing 25–30 g were put randomly into test
and control groups, each group containing five mice and
were supplied with adequate amount of mouse cubes
and clean drinking water. The plasmodium strain used
for the test was P. berghei, a chloroquine sensitive rodent
malaria parasite, obtained from the Drug Research De-
partment of the Ethiopian Public Health Institute. The
parasitized erythrocytes for each test were collected from
an infected donor mouse with rising parasitaemia of 20–
30 %. The mice were sacrificed by head blow, and blood
was collected in a Petri dish with an anticoagulant
(0.5 % trisodium citrate) by severing the jugular vein.
The blood was then diluted with physiological saline
(0.9 %) in proportion of 1:4. Each mouse was then inoc-
ulated with 0.2 mL of blood containing about 107P. ber-
ghei infected erythrocytes on day 0 through intra
peritoneal route. After three hours of parasite inocula-
tion, three test groups of mice were administered with
200, 400 and 800 mg/kg of the crude extracts. Similarly,
in fraction treated mice, three test groups of infected
mice were treated with 100, 200 and 400 mg/kg of the
fractions. The negative control group mice were treated
with 0.2 mL of the vehicle (distilled water) and the posi-
tive control groups were treated with 10 mg/kg of
chloroquine.
Determination of parasitaemia
On the fifth day, a drop of blood was taken from tail
snip of each mouse on frosted slide and smears were
prepared, fixed with methanol and stained with 10 %
Giemsa solution at pH 7.2 for 15 min. Then, five fields
were randomly selected on each stained slide and exam-
ined under microscope with an oil immersion objective
(×100 magnification power). The parasitaemia level was
determined by counting the number of parasitized eryth-
rocytes on randomly selected fields of the slide. Percent-
age of parasitaemia and suppression was calculated
using the formulas [27] given below.
% Parasitaemia ¼ Number of parasitized RBCx100
Total number of RBC counted
% of suppression
¼
Parasitaemia in negative control
–Parasitaemia in treated group
 !
x100
Parasitaemia in negative control
Determination of mean body weight and survival time
The body weight was determined by taking average
weight of mice in each test group and comparing it with
that of infected negative controls. Mortality was moni-
tored daily and the number of days from the time of in-
oculation of the parasite up to death was recorded for
each mouse in the treatment and control groups
throughout the follow up period. The mean survival
time (MST) for each group was calculated as given
below.
MST ¼ Sum of survival time daysð Þ of mice in group
Total numbers of mice in that group
Determination of the packed cell volume (PCV)
Blood was collected from sniped tail of each mouse in
heparinized microhaematocrit capillary tubes. Each ca-
pillary tube was sealed by crystal seal and placed in a
micro-hematocrit centrifuge (Hettich haematokrit,
Germany) with the sealed ends out wards. Blood that
was filled to three fourth of the capillary tubes was cen-
trifuged at 12,000 rpm for 5 min. The volume of the
total blood and the volume of erythrocytes were mea-
sured and PCV was calculated using the formula:
PCV ¼ Volume of RBC in a givenblood volumex 100
Total blood volume
Data analysis
The collected data were organized, entered into Micro-
soft Office Excel 2007 and exported to Windows SPSS
20.1. Frequencies and percentages were calculated from
the data using the Excel 2007. Data on parasitaemia, sur-
vival day, body weight and packed cell volume were ana-
lyzed using Windows SPSS version 20.1. One way
ANOVA and paired sample t-test were used to compare
results within groups for difference between initial (be-
fore) and final (after) treatments. Results obtained from
the study were presented as mean plus or minus stand-
ard error of the mean (M ± SEM). All data were analyzed
at 95 % confidence interval (α =0.05).
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Results
Percentage yield of extracts
The yield of the extracts obtained from the five antimal-
arial plants was in the range of 10–50 g. The highest
percentage of yield was obtained from A. integrifolia
(30.0 %) and the lowest from P. schimperi (18.0 %)
(Table 1). The physical nature of the extracts showed
that crude extracts of leaf and areal parts were semi
solid (gumy), while extracts from bark were solid.
Acute toxicity test of crude extracts
Acute toxicity test conducted to determine the safety
level of crude extracts of the five plants showed that the
lethal dose of all extracts was above 2000 mg/kg. All ex-
tracts that were administered orally in a single dose of
2000 mg/kg to the laboratory bred Swiss albino mice
caused no lethal effect within 24 h of the observation
period. The gross behavioral and physical observation of
the experimental mice also revealed that the extracts
created no visible signs of acute toxicity such as lacrima-
tion, hair erection and reduction in their motor and
feeding activities. The mice were physically active and
fed and drunk as that of the control groups administered
with the vehicle (distilled water) within the observation
period of 10 days.
In vivo antimalarial test of crude extracts
Result of the four-day suppressive test of the crude ex-
tracts of the five antimalarial plants at different dose
levels on mice infected with P. berghei expressed as per-
cent of reduction of parasitaemia in reference to the
negative control mice is summarized in Table 2. The re-
sult indicated that all the crude extracts of the five anti-
malarial plants exhibited antiplasmodial activity. The
extracts reduced parasitaemia to different levels in dose
dependant manner. The highest inhibition was exhibited
by crude extract of A. integrifolia (35.17 ± 1.95) at
800 mg/kg/day and the lowest by Premna schimperi
(2.27 ± 0.07) at 200 mg/kg/day.
Comparison of each test group to their respective
negative control groups at different dose level indicated
that the crude extracts of A. integrifolia reduced parasit-
aemia to significant level on day 4 (p < 0.05) at doses of
200, 400 and 800 mg/kg. The crude extract of M. aze-
darach also reduced parasitaemia to significant level on
day 4 (p < 0.05) at doses of 400 and 800 mg/kg. In
addition, extract of C. myricoides reduced parasitaemia
significantly on day 4 only at dose of 800 mg/kg (p <
0.05). Parasite reduction induced by extracts of P. schim-
peri and P. vogelii was not significant (P > 0.05) at all the
three doses.
Determination of mean survival time of extract treated
mice
Result of the survival time of mice treated with differ-
ent doses of the 80 % methanol extract (Table 3) in-
dicated that treated mice survived for more days than
the respective negative control groups. Moreover, the
highest survival time was recorded in mice that re-
ceived the highest dose of extracts. Among extract-
treated mice, those treated with 800 mg/kg/day of
crude extract of A. integrifolia survived for longer
time with mean survival time of 12.00 ± 0.44. Mice
that were treated with crude extract of P. schimperi
survived for shorter time with mean survival days
(7.4 ± 0.24) at oral dose of 200 mg/kg/day.
Comparison of the mean survival time of each test
group with the respective negative controls at different
dose level indicated that the crude extracts of A. integri-
folia and M. azedarach prolonged the mean survival
time of mice significantly (P < 0.05) at doses of 200, 400
and 800 mg/kg/day. Extract of C. myricoides prolonged
the survival time of mice significantly (P < 0.05) at doses
of 400 and 800 mg/kg/day. Extracts of P. schimperi and
P. vogelii prolonged the survival time of mice signifi-
cantly (P < 0.05) only at the highest dose of 800 mg/kg.
Determination of mean weight of extract treated mice
In general, the mean weight of mice that received 80 %
methanol extracts (Table 4) increased on day 4 post in-
fection as compared to that of mice on day 0. The
weight of mice increased dose dependently. Mice that
were given the highest dose showed more weight incre-
ment than mice that received the lowest dose. The high-
est percentage of weight change value was recorded for
mice treated with 800 mg/kg/day of A. integrifolia ex-
tract (10.58 ± 0.68). While the least was recorded for
mice that received 200 mg/kg/day of crude extracts of P.
schimperi (2.10 ± 0.24).
Moreover, the comparison of mean weight of extract
treated mice to respective controls at each dose level in-
dicated that extracts of A. integrifolia, C. myricoides and
M. azedarach prevented weight loss significantly (P <
0.05) at dose of 200, 400 and 800 mg/kg. Wheareas, the
weight loss prevention of mice treated with extracts of
P. schimperi and P. vogelii was not significant (P > 0.05)
at 200 mg/kg but significant (P < 0.05) at 400 and
800 mg/kg as compared to the respective negative con-
trol of mice treated with distilled water.
Table 1 Yield of 80 % methanol extracts of medicinal plant
Scientific name Sidama name Habit Part used % yield
Ajuga integrifolia Anamuro Herb Aerial 30.0
Clerodendrum myricoides Madisisa Herb Leaf 20.0
Melia azedarach Mime Tree Twig 24.7
Peponium vogelii Surupa Climber Leaf 27.3
Premna schimperi Udo Shrub Leaf 18.0
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Table 2 Effect of 80 % methanol crude extract of medicinal plants on parasitaemia level of P. berghei infected Swiss albino mice
Medicinal plant Dose
mg/kg/day
D4 post-infection P value
% parasitaemia (M ± SEM)D4 % suppression (M ± SEM)
Ajuga integrifolia 200 42.56 ± 1.80*a 21.06 ± 1.27 0.000
400 40.49 ± 1.40*a 24.87 ± 1.54 0.000
800 34.92 ± 1.20*a 35.17 ± 1.95 0.000
Clerodendrum myricoides 200 52.19 ± 1.13 3.88 ± 1.36 0.851
400 49.95 ± 1.60 7.18 ± 1.94 0.166
800 45.78 ± 1.49*a 14.99 ± 2.02 0.001
Melia azedarach 200 50.96 ± 1.50 5.43 ± 1.50 0.462
400 42.95 ± 1.60*a 21.75 ± 1.31 0.000
800 36.84 ± 1.22*a 31.54 ± 2.18 0.000
Peponium vogelii 200 54.48 ± 1.06 2.62 ± 0.89 0.789
400 53.23 ± 0.89 5.54 ± 0.60 0.337
800 51.99 ± 0.85 7.20 ± 0.77 0.074
Premna schimperi 200 56.70 ± 0.83 2.27 ± 0.70 0.933
400 55.90 ± 0.64 2.63 ± 0.31 0.486
800 54.78 ± 0.65 4.56 ± 0.58 0.066
NC 0 53.84 ± 0.83 0.00 ± 0.00
PC 10 0.00 ± 0.0 100 ± 0.00
Values are expressed as M ± SEM; n = 5
NC negative control (0.2 mL of dH2O); PC positive control (chloroquine), D4 day four
*P < 0.05
acompared to negative control
Table 3 Effect of 80 % methanol crude extracts of medicinal plants on mean survival time of P. berghei infected Swiss albino mice
Medicinal plant Dose mg.kg/day Mean survival time (M ± SEM) P value
A. integrifolia 200 9.40 ± 0.24*a 0.000
400 9.80 ± 0.38*a 0.000
800 12.00 ± 0.44*a 0.000
C. myricoides 200 8.20 ± 0.20 0.141
400 9.00 ± 0.31*a 0.015
800 10.00 ± 0.39*a 0.002
M. azedarach 200 8.60 ± 0.24*a 0.032
400 9.30 ± 0.37*a 0.011
800 10.90 ± 0.58*a 0.001
P. vogelii 200 7.80 ± 0.20 0.454
400 8.20 ± 0.24 0.227
800 9.20 ± 0.37*a 0.017
P. schimperi 200 7.40 ± 0.24 0.307
400 8.00 ± 0.31 0.084
800 9.40 ± 0.50*a 0.030
NC 0 6.40 ± 0.24
PC 10 30.00 ± 0.00
Values are expressed as M ± SEM; n = 5
NC negative control (0.2 mL of dH2O), PC positive control (Chloroquine)
* = P < 0.05
a = compared to negative control
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A paired sample t-test comparison between day 0
(pre treatment) and day 4 (post treatment) indicated
that weight increment of mice treated with extracts of
A. integrifolia and M. azedarach was statistically sig-
nificant (P < 0.05) at doses of 200, 400 and 800 mg/
kg/day on day 4. In mice treated with extract of C.
myricoides, the body weight increment of mice was
significant (P < 0.05) at doses of 400 and 800 mg/kg.
While in mice treated with extracts of P schimperi
and P. vogelii, the weight increased significantly (P <
0.05) only at a dose of 800 mg/kg/day.
Determination of mean packed cell volume of extract
treated mice
The mean value of the packed cell volume (PCV)
showed reduction in mice treated with extract (Fig. 1)
and in those that were treated with the vehicle on D4
(post treatment) as compared to D0 (pre treatment).
However, result of comparison between D0 and D4 of
extract treated mice with the respective negative control
groups showed no appreciable reduction.
The comparison of PCV change of extracts treated
mice at different dose levels with the respective negative
controls treated with the vehicle indicated that the PCV
value of mice treated with crude extracts of A. integrifo-
lia and M. azedarach deviated significantly from the
negative controls (P < 0.05) at doses of 200, 400 and
800 mg/kg/day. The deviation of PCV value of mice
treated with extract of C. myricoides was significant (P <
0.05) at doses of 400 and 800 mg/kg/day. Whereas, in
the case of mice treated with extracts of P. schimperi
and P. vogelii, the deviation was significant (P < 0.05)
only at the highest dose (800 mg/kg). The paired sample
t-test result between D0 and D4 of mice treated with ex-
tracts at doses of 200, 400 and 800 mg/kg/day indicated
significant decrease (P < 0.05) of PCV value on D4.
Percentage yield of fractions of Ajuga integrifolia
The highest percentage of yield was obtained from n-
butanol fraction (35.0 %) of the aerial part of A. integrifo-
lia, followed by that of water (24.7 %) and chloroform
(17.0 %). There was also variation in the physical appear-
ance of the fractions. The water fraction was sticky and
solid while that of n-butanol and chloroform fractions
were jelly.
Phytochemical tests on extract of Ajuga integrifolia
Result of phytochemical screening tests on the extract of
A. integrifolia revealed the presence or absence of main
secondary metabolites and other phytochemicals based
on presence or absence of expected colour changes
(Table 5). The methanol extract of A. integrifolia con-
tained alkaloids, terpenoids, flavonoids, steroids, sapo-
nins, tannins, anthraquinone, phenols and fats and oils.
In vivo antimalarial tests of fractions of Ajuga integrifolia
Result of the four-day suppressive test of the three frac-
tions at different dose levels on parasitaemia level of
mice infected with P. berghei is summarized in Table 6.
The result is expressed as the percent of reduction of
parasitaemia in reference to the negative control mice
treated with the vehicle. As the result indicated, the
three fractions exhibited antiplasmodial activity in vivo
against P. berghei. The fractions reduced parasitaemia to
different levels in dose-dependant manner. The highest
inhibition of parasitaemia was exhibited by n-butanol
Table 4 Effect of 80 % methanol crude extracts of medicinal










Pre (D0) Post (D4)
A. integrifolia 200 29.52 ± 0.29 31.30 ± 0.44 6.01 ±
0.51*a
0.000
400 27.60 ± 0.14 29.08 ± 0.32 8.56 ±
0.83*a
0.000
800 26.86 ± 0.28 29.76 ± 0.51 10.58 ±
0.68*a
0.000
C. myricoides 200 26.06 ± 0.21 27.34 ± 0.12 4.18 ±
0.60*a
0.006
400 28.82 ± 0.28 30.20 ± 0.14 5.84 ±
0.75*a
0.000
800 25.94 ± 0.15 27.98 ± 0.23 7.55 ±
0.67*a
0.000
M. azedarach 200 25.56 ± 0.11 26.70 ± 0.09 4.49 ±
0.38*a
0.000
400 26.78 ± 0.18 28.52 ± 0.30 6.56 ±
0.63*a
0.000
800 28.98 ± 0.26 31.32 ± 0.59 8.78 ±
0.89*a
0.000
P. vogelii 200 26.64 ± 0.18 27.52 ± 0.23 2.29 ±
0.39
0.062
400 28.60 ± 0.31 29.88 ± 0.30 4.48 ±
0.32*a
0.037
800 28.18 ± 0.31 30.02 ± 0.54 6.52 ±
0.95*a
0.008
P. schimperi 200 26.70 ± 0.41 27.46 ± 0.48 2.1 ±
0.24
0.065
400 29.24 ± 0.25 30.14 ± 0.15 4.0 ±
0.31*a
0.031
800 29.38 ± 0.28 31.10 ± 0.33 5.4 ±
0.50*a
0.042
NC 0 25.56 ± 0.24 24.10 ± 0.36 −5.56 ±
0.72
PC 10 26.52 ± 0.50 29.56 ± 0.49 10.73 ±
0.50
Values are expressed as M ± SEM; n = 5
NC negative control (0.2 mL of dH2O), PC positive control (Chloroquine), D4
day four
*P < 0.05
acompared to negative control
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fraction (29.80 ± 0.66) at 400 mg/kg/day and the lowest
by chloroform fraction (3.68 ± 0.83) at 100 mg/kg/day.
The comparison of the test groups to their respective
negative controls indicated that the n-butanol fraction
reduced parasitaemia to significant level on day 4 (p <
0.05) at the doses of 100, 200 and 400 mg/kg/day. Water
fraction reduced parasitaemia to significant level (p <
0.05) at doses of 200 and 400 mg/kg/day. Parasite reduc-
tion of chloroform fractions was not significant (p >
0.05) at all the three doses.
Although the extracts and fractions reduced parasite
load in treated group of mice, none of the crude extracts
or fractions completely cleared the parasite. In the posi-
tive control group of mice treated with standard anti-
malarial drug chloroquine phosphate, at daily dose of
10 mg/kg body weight, the parasite was totally cleared
on day four-post infection.
Determination of mean survival time of fraction treated
mice
Result of the mean survival time of mice treated with
different doses of the fractions of A. integrifolia (Fig. 2)
indicated that treated mice survived for more days as
compared with those in the negative control group with
the highest survival time recorded for mice that received
the highest dose of n-butanol fraction (400 mg/kg/day).
Comparison of the mean survival time of fraction
treated mice to the negative controls at different dose
levels showed that the mean survival time of mice that
were treated with n-butanol fraction was prolonged
Fig. 1 Effect of 80 % methanol crude extracts of medicinal plants on PCV of P. berghei infected Swiss albino mice. Keys: Vehicle (NC) = negative
control; D0 = day 0; D4 = day 4; PCV = Packed Cell Volume; (n = 5)
Table 5 Phytochemical constituents of 80 % methanol extract of A. integrifolia
Test Reagents Test result
Alkaloid Wagner’s reagent ++
Terpenoids Chloroform, acetic anhydride, concentrated sulphuric acid ++
Flavonoids Magnesium ribbon, concentrated hydrochloric acid ++
Steroids Chloroform, concentrated H2SO4 +
Tannin 10 % ferric chloride (FeCl3) +
Saponins distilled water ++
Anthraquinone KOH +
Phenol ferric chloride +
Proteins Millions reagent −
Carbohydrate Fehling solution, HCl, NaOH −
Fats and oils Filter paper +
+++ = very strong positive, ++ = strong positive, + = fair positive, _ = absent
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significantly (P < 0.05) at doses of 100, 200 and 400 mg/
kg/day. Water fraction prolonged the survival time of
mice significantly (P < 0.05) at doses of 200 and 400 mg/
kg/day. While, chloroform fraction prolonged the mean
survival time of mice significantly (P < 0.05) at oral dose
of 400 mg/kg/day.
Determination of mean weight of fraction treated mice
In general, the mean weight of mice that received frac-
tions of A. intefrifolia (Table 7) increased on day 4 post
infection as compared to that of day 0. The weight of
mice increased dose dependently. Mice that were given
the highest dose showed more increment than mice that
received the lowest dose. Among treated groups, the
highest weight change (9.40 ± 0.58) was recorded for
mice treated with 400 mg/kg/day of n-butanol fraction





D4 post infection P value
% of Parasitaemia (M ± SEM) % of inhibition (M ± SEM)
Water 100 43.20 ± 1.65 9.72 ± 1.27 0.091
200 42.40 ± 1.50*a 11.29 ± 1.01 0.035
400 36.60 ± 1.21*a 23.44 ± 1.10 0.001
n-Butanol 100 42.20 ± 1.06*a 11.80 ± 2.09 0.026
200 39.80 ± 1.28*a 17.16 ± 0.94 0.014
400 35.80 ± 1.28*a 29.80 ± 0.66 0.000
Chloroform 100 47.00 ± 1.41 3.68 ± 0.83 0.752
200 46.20 ± 1.49 5.78 ± 11.69 0.494
400 47.80 ± 1.39 9.80 ± 3.41 0.157
NC 0 49.20 ± 1.50 0.00 ± 0.00
PC 10 0.00 ± 0.00 100.00 ± 0.00
Values are expressed as M ± SEM; n = 5
NC negative control (0.2 mL of dH2O), PC positive control (Chloroquine), D4 day four
*P < 0.05
acompared to negative control
Fig. 2 Effect of butanol, water and chloroform fractions of A.
integrifolia on mean survival time of P. berghei infected Swiss albino
mice. (n = 5). Keys: BF = butanol fraction; WF = water fraction; CF =
chloroform fraction; NC = negative control
Table 7 Effect of water, butanol and chloroform fractions on










Water 100 26.20 ± 0.44 27.06 ± 0.46 3.28 ±
0.24*a
0.027
200 28.14 ± 0.39 29.82 ± 0.48 6.10 ±
0.30*a
0.018
400 28.80 ± 0.17 31.28 ± 0.13 9.03 ±
0.32*a
0.000
n-Butanol 100 27.64 ± 0.09 28.80 ± 0.20 3.19 ±
0.51*a
0.033
200 27.96 ± 0.06 29.38 ± 0.10 6.23 ±
0.48*a
0.026
400 28.52 ± 0. 13 30.40 ± 0.21 6.59 ±
0.58*a
0.000
Chloroform 100 26.34 ± 0.25 26.94 ± 0.31 2.26 ±
0.32
0.080
200 27.12 ± 0.31 28.04 ± 0.39 3.67 ±
0.46
0.072
400 29.08 ± 0.27 30.58 ± 0.4 5.14 ± 0
.42*a
0.031
NC 0 26.80 ± 0.33 25.86 ± 0.27 −2.41 ± 0.
.92
PC 10 27.38 ± 0.51 28.94 ± 0.62 5.00.95 ±
0.71
Values are expressed as M ± SEM; n = 5
NC negative control (0.2 mL of dH2O), PC positive control (Chloroquine)
*P < 0.05
acompared to negative control
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and the least (2.26 ± 0.32) for mice that received
100 mg/kg of chloroform fraction. Moreover, the com-
parison of mean weight of fraction treated mice to
respective controls at each dose level indicated that
n-butanol and water fractions prevented weight loss of
mice significantly at 100, 200 and 400 mg/kg/day doses
(P < 0.05). Whereas, chloroform fractions prevented
weight loss significantly only at 400 mg/kg/day (P < 0.05)
as compared to the respective negative control mice. A
paired sample t-test comparison between D0 and D4 in-
dicated significant (P < 0.05) weight increment of mice
treated with n-butanol and water fractions at dose of
100, 200 and 400 mg/kg/day.
Determination of mean packed cell volume of fraction
treated mice
The mean value of the packed cell volume (PCV)
showed reduction in mice treated with fractions of A.
integrifolia and those in the negative control group on
D4 as compared to D0 (Fig. 3, Fig. 4 and Fig. 5). How-
ever, result of comparison of PCV of D0 and D4 fraction
treated mice with that of the respective PCV of mice in
the negative control group showed no appreciable re-
duction. The comparative test indicated that PCV values
of mice that were treated with n-butanol and water frac-
tions deviated significantly (P < 0.05) at doses of 100, 200
and 400 mg/kg/day from that of the mice in the negative
control group. The deviation of the PCV value of mice
treated with chloroform fraction from that of mice in
the negative control group was significant (P < 0.05) only
at dose of 400 mg/kg/day. The paired sample t-test re-
sult between D0 and D4 of mice treated with water, n-
butanol and chloroform fractions at doses of 100, 200
and 400 mg/kg/day indicated that on day 4, the PCV
value showed significant reduction in all test group
mice(P < 0.05).
Discussion
As findings of the acute toxicity test indicate, no gross
behavioral changes such as impaired movement, reduced
motor activity and mortality were manifested in mice
that were treated with single dose of 2000 mg/kg. The
methanol extract treated mice were in the same condi-
tion as that of the control group mice that were treated
with distilled water over the observation time of ten
days. Thus, the extracts of the tested medicinal plants
parts could be considered safe at the dose levels used in
this the experiment. The result, therefore, justify the use
of such plant parts by the Sidama people for the treat-
ment of malaria. Toxicity tests carried out elsewhere on
extracts of the plants Melia azedarach [28], C. myri-
coides [29] and Ajuga spp. [30] also showed their safety
on laboratory animals at doses of 2000 mg/kg and
above.
The methanol extracts of the five medicinal plants re-
duced the malaria parasite load in mice during the four-
day suppressive test suggesting their suppressive effect
on the blood stage of the parasite. Among the extracts,
parasite load was decreased significantly in mice treated
Fig. 3 Effect of water fraction of A. integrifolia on PCV of P. berghei
infected Swiss albino mice. Keys: WF = water fraction; NC = negative
control; D0 = Day 0; D4 = Day 4; PCV = Packed Cell Volume; (n = 5)
Fig. 4 Effect of butanol fraction of A. integrifolia on PCV of P. berghei
infected Swiss albino mice. Keys: BF = butanol fraction; NC = negative
control; D0 = Day 0; D4 = Day 4; PCV = Packed Cell Volume; (n = 5)
Fig. 5 Effect of chloroform fraction of A. integrifolia on PCV of P.
berghei infected Swiss albino mice. Keys: CF = chloroform fraction;
NC = negative control; D0 = Day 0; D4 = Day 4; PCV = Packed Cell
Volume; (n = 5)
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with extract of A. integrifolia at all the three doses (200,
400 and 800 mg/kg/day). The highest suppression was
recorded for A. integrifolia at the highest test dose of
800 mg/kg/day. An investigation carried out elsewhere
also indicated high level (90.4 %) of suppression of para-
sitaemia in mice treated with water extract of Ajuga
remota, a close relative of A. integrifolia, at a dose of
30 mg/kg [17]. A study by Irungu et al. [18] revealed
that aqueous, methanol and dichloromethane extracts of
the root bark extracts of C. myricoides exhibited anti-
malarial activities in vitro with IC50 values of 64 μg/mL,
48.2 μg/mL, 15.8 μg/mL, respectively. Bark extract of
Melia azedarach was reported to show in vitro antiplas-
modial activity with IC50 value of 66.2 μg/mL [19].
However, the extracts did not eradicate the parasite
completely unlike the standard chloroquine drug. As day-
to-day observation during post treatment period indicated,
clinical symptoms of the infection were seen in the treated
mice due to gradual increment of the parasitaemia. The
subsequent development of the parasitaemia in all the ex-
tracts treated mice might suggest that the actions of the
extracts were short-lived due to their rapid metabolism or
elimination [31]. The limited effect also might be related
to partial loss of active ingredients due to its insufficient
uptake to physiologically active level [32].
Although the mechanism of action of the extracts was
not explained, the reduction of parasite load in the
treated mice might be due to the presence phytochem-
ical constituents such as alkaloids, flavonoids, and terpe-
noids. Previous studies have indicated the potential of
alkaloids, terpenoids, flavonoids, coumarins, phenolics,
polyacetylenes, xanthones, quinones, steroids and lig-
nans for antimalarial drug development [33, 34]. Ajuga
remota, a related species of A. integrifolia, was reported
to have shown antimalarial activity due to the presence
of terpenoids [33]. Another report also indicated the
antimalarial activity of the compounds triterpenoids and
limonoids [35].
In vivo evaluation of the n-butanol, water and chloro-
form fractions of A. integrifolia indicated that the n-
butanol and water fractions of the plants suppressed para-
sitaemia to a significant level at all the three doses (100,
200 and 400 mg/kg/day). The relatively high antimalarial
action of the n-butanol fraction could be the result of a
single or synergistic effect of the secondary metabolites
such as alkaloids, saponins, flavonoids, tannins and phe-
nols found in the fraction [36]. The result of the present
study is in agreement with findings documented by Yared
et al. [37] and Mengiste et al. [38], where n-butanol frac-
tion of A. africanus and D. angustifolia significantly sup-
pressed parasitaemia in treated mice. The water fraction
also reduced parasitaemia dose dependently but the level
of activity was less as compared to that of n-butanol, indi-
cating the difference in the type and concentration of the
different secondary metabolites in the fractions [39]. The
insignificant parasitaemia reduction by chloroform frac-
tion may be due to less concentration of secondary metab-
olites available in the extract.
Comparison of the activity of the crude extract of A.
integrifolia with that of its fractions showed that the
fractions (n-butanol, water and chloroform) demon-
strated less antiplasmodial activity. The relatively higher
potency of the crude extract may be attributed to the
presence of various phytochemical constituents that
work singly or synergistically, but might be reduced or
lost during fractionation. Some secondary metabolites
protect other metabolites (as antioxidants) and breaking
of this association could accelerate degradation and con-
sequently reduction of the suppressive effect of the in-
gredients [40]. Similar finding was reported indicating
greater chemossuppression induced by water extracts of
Ageratum conyzoides as compared to that of methanol,
water and chloroform [41]. Eighty percent methanol leaf
extract of Otostegia integrifolia also showed to have high
antimalarial activity than its respective ethanol, water
and chloroform fractions [42].
Treatment with the plants crude extracts and fraction
extended survival time of mice in the treatment groups
as compared with the mice in non-treated control
groups. The survival time of the extract and fraction
treated mice for more days in the presence of the para-
site might be due to the phytochemical ingredients,
which have antioxidant property that reduce the overall
pathologic effect of the parasite and prolong the survival
time of mice as compared to those in the negative con-
trol group. Phytochemical constituents such as flavo-
noids and tannins have been suggested to act as primary
antioxidant or free radical scavengers that aid antioxi-
dant defense system and reduce oxidative stress that is
induced by the malaria parasite [43].
Body weight loss is one of the features observed in ro-
dents infected with malaria parasite due to poor appetite
that develops because of the intensity of the infection
[44]. During the period of 4-day suppressive test, the ex-
tracts and fractions protected mice from losing weight.
The weight of the negative control mice decrease tre-
mendously where as the weight of crude extracts and
fractions treated mice increased gradually. The weight
increment in treated mice might be due to the ex-
tracts or fractions pharmacological effect that coun-
teract other aspects of malaria illness such as fever,
immunosuppression and pain. Mice treated with ex-
tracts of A. integrifolia, C. myricoides, M. azedarach
and P. vogelii significantly prevented weight loss in
dose dependant fashion. Our finding was consistent
with other studies [45–47] where mice treated with
extracts of different plants showed weight increment
dose dependently.
Asnake et al. BMC Complementary and Alternative Medicine  (2015) 15:448 Page 10 of 12
Malaria-caused anemia occurs due to hemolysis of red
blood cells because of destruction of infected and unin-
fected red blood cells as well as erythropoietic suppression
and dyserythropoiesis [48]. The PCVs of malaria-infected
mice that were treated with the extracts and fractions
were reduced on the 4th day of post infection. The reduc-
tion of PCV in the treated mice might be related to the
different phytochemical components present in tested
plants. Some studies indicated that saponins are known to
cause hemolysis by increasing the permeability of plasma
membrane of the red blood cells [49]. The methanol ex-
tracts and fractions prevented a drastic reduction in PCV
in infected mice as compared with that in the negative
control. This shows the role of the extracts and fractions
in preventing radical anemic conditions that were mani-
fested in mice in negative control due to severe infection.
This could be due to the marked decrease in parasite load
in the course of infection in mice treated with the extracts
and fractions in dose dependant manner. In the untreated
mice, the parasite number increased and consequently
destroyed more red blood cells and so resulted in marked
decrease of hematocrit PCV.
Conclusions
Acute toxicity test result of methanol crude extracts of
the tested plants showed no sign of toxicity in mice
treated up to a dose of 2000 mg/kg, supporting their
traditional use. In vivo antimalarial test results indicated
that crude extracts and fractions of the plant materials
showed potent antimalarial activity in dose dependant
fashion. Especially, the crude extract and n-butanol and
water fractions of A. integrifolia showed significant che-
mosuppression, justifying the local use of the plants to
treat malaria. Further in vivo and in vitro investigations
are recommended to evaluate, in detail, the antiplasmo-
dial activity and safety of the plants.
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